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Abstract
Objective: The objective of this study was to investigate whether the infection of C57BL/6 mice
by P. berghei ANKA, which causes severe malaria, was modulated by co-infection with Trypanosoma
cruzi.
Methods: Groups of C57BL/6 mice were infected either with P. berghei ANKA, T. cruzi strain G,
or with both parasites. The presence of parasites was checked by microscopic examination of
blood samples. Symptoms of neurological or respiratory disorders, as well as mortality, were
registered. Breakdown of the blood brain barrier was determined by injecting the dye Evans blue.
Histological sections of the lung were prepared and stained with hematoxilin-eosin.
Results: All mice infected only with P. berghei ANKA died within 7–11 days post-infection, either
with symptoms of cerebral malaria or with respiratory abnormalities. The animals co-infected with
T. cruzi strain G survived longer, without any of the referred to symptoms. Protection against the
early death by severe malaria was effective when mice were given T. cruzi 15 days before P. berghei
inoculation. Breakdown of the blood brain barrier and extensive pulmonary oedema, caused by
malaria parasites, were much less pronounced in co-infected mice. The degree of protection to
severe malaria and early death, conferred by co-infection with T. cruzi, was comparable to that
conferred by treatment with anti-CD8 antibodies.
Conclusion: Co-infection with T. cruzi protects C57BL/6 against the early death by malaria
infection, by partially preventing either the breakdown of the blood brain, and cerebral malaria as
a consequence, or the pulmonary oedema.
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Multiple infections by parasitic agents that cause diverse
clinical manifestations occur frequently and increase or
decrease of overall pathogenic impact can be influenced
by synergistic or competitive interactions between para-
site species [1,2]. Malaria is prevalent throughout tropical
regions where concomitant infections occur frequently.
Double infections with Plasmodium spp. and Ascaris lum-
bricoides, or triple infections with the two parasites plus
Trichuris trichiura, without synergism or antagonism
among parasites, have been reported in Zaire [3]. Con-
comitant parasitism by agents of malaria and lymphatic
filariasis, with no indication of interaction between the
two infections, has been detected in India and in Guyana
[4,5]. On the other hand, it has been found that Senega-
lese children lightly infected with Schistosoma haemato-
bium had lower Plasmodium falciparum densities,
suggestive of negative interactions between both parasites
[6]. It has been pointed out that, if worms have in fact del-
eterious effect on malaria, treatment of helminthic infec-
tion would offer an affordable and effective means to roll
back malaria [7]. Experiments in mice have shown that
malaria-filaria co-infection causes more severe anaemia
and loss of body mass than Plasmodium chabaudi malarial
infection alone [8], and that concomitant P. chabaudi and
Schistosoma mansoni infections increase malaria parasitae-
mia and suppress spleen cell proliferative and Th2
responses to S. mansoni soluble egg antigen [9]. Using
Plasmodium berghei ANKA, which causes lethal cerebral
malaria in C57BL/6J mice, Legesse et al. [10] found that
superinfection with S. mansoni enhanced malaria parasite
development, increasing parasitaemia and mortality.
As regards the mixed infection by malaria parasite and
another protozoan, the data are sparse. The possibility, for
instance, of co-infection with Trypanosoma cruzi, the agent
of Chagas' disease, has not been examined. In Brazil, as
there has been an increase in cases of Chagas' disease in
the Amazon, where malaria prevails, recommendations
have been made to include the microscopic analysis of
blood smears for direct search of T. cruzi in patients with
fever in the routine survey for malaria parasites [11].
Thirty years ago, Krettli [12] reported that in double infec-
tion with P. berghei NK65 and T. cruzi about 40% of mice
chronically infected with T. cruzi relapsed to the acute
phase when inoculated with P. berghei, while some
decrease in P. berghei parasitaemia was observed. Since
then, the question has not been further addressed. This
study aimed at investigating if, and to what extent, the
agents of malaria and Chagas' disease exerted their effects
to each other's course of infection. To that end, P. berghei
ANKA, which produces cerebral malaria in C57BL/6 mice,
and a T. cruzi strain from the Amazon, which produces
subpatent infection, were used.
Methods
Parasites and infection of mice
P. berghei ANKA was conserved as stabilates of 107 parasi-
tized erythrocytes in liquid nitrogen. When needed, the
parasites were defrosted and injected intraperitoneally
into C57BL/6 mice and seven days later these served as the
inoculum to infect mice. C57BL/6 mice bred in the ani-
mal facility (CEDEME), at Universidade Federal de São
Paulo, were used throughout. All procedures and experi-
ments conformed to the regulations of the institutional
Ethical Committee for animal experimentation. In all
assays, mice were infected with P. berghei by inoculating
intraperitoneally 106 parasitized erythrocytes. Parasitae-
mia was monitored by reading Giemsa-stained blood
smears. The T. cruzi G strain, isolated from an opossum in
the Brazilian Amazon [13] was maintained cyclically in
Swiss mice and in liver infusion tryptose medium. Infec-
tive metacyclic trypomastigotes from cultures at the sta-
tionary growth phase were purified by passage through
DEAE-cellulose column, as described earlier [14]. For
standard co-infection experiments, C57BL/6 mice were
inoculated intraperitoneally with 106 T. cruzi metacyclic
forms, and 15 days later they received 106 erythrocytes
parasitized with P. berghei ANKA. The T. cruzi parasitaemia
was checked by counting the parasites in 5 μl fresh blood
collected from the mouse tail, under phase-contrast
microscope.
Injection of Evans blue into mice and removal of the brain
The dye Evans blue was prepared as a 1% solution in PBS
and each mouse received 0,2 ml through intraorbital
route. When P. berghei-infected mice showed signs of neu-
rological disorder, such as deviation of the head, convul-
sion and paralysis, they were given the dye and one hour
later the brain was removed. Each time a P. berghei-
infected mouse received the dye, a co-infected mouse and
a mouse infected only with T. cruzi, were injected with the
dye and their brain collected one hour later. The brains
were stored at 4°C in a petri dish with PBS, and at the end
of the experiment their images were recorded with a dig-
ital camera.
Preparation of histological sections of mouse lung
Experiments in which P. berghei-infected mice presented
respiratory disorders, right after death their lungs were
collected and fixed in 10% neutral buffered formalin for
24 h. Afterwards, the organs were gradually dehydrated in
ethanol solution at different concentrations, followed by
immersion in xylol, and then embedded in paraffin. Serial
sections, 5 μm thick, were prepared and stained with
hematoxylin-eosin. Equivalent numbers of symptomless
mice, co-infected with T. cruzi, were also killed and their
organs processed as above.Page 2 of 6
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Mice infected with P. berghei ANKA only, or co-infected
with T. cruzi, were treated with anti-CD8 antibodies (0.3
ml/mouse of ascitic fluid from clone TIB 21O by intraperi-
toneal injection), on days 0 and 5 of malaria infection.
Results and Discussion
Co-infection with T. cruzi protects mice from early death 
by P. berghei ANKA
T. cruzi G strain was used because it produces a non lethal
subpatent infection in mice, even when the animals are
inoculated with a number of parasites as high as 8 × 106
[13]. C57BL/6 mice were separated in three groups, two of
which were inoculated with 106 metacyclic forms of T.
cruzi G strain. Fifteen days later, one uninfected and one
T. cruzi-infected group were inoculated with 106 erythro-
cytes parasitized with P. berghei ANKA. Four days later,
monitoring of mortality and course of infection was initi-
ated. Fifty percent of P. berghei-infected mice were dead by
day 7, and by day 11 there was not a single survivor,
whereas co-infected mice survived longer, 50% of them
being alive by day 17 (Figure 1A). A five-week T. cruzi
infection was less effective than a two-week infection in
protecting against early death by severe malaria. In exper-
iments in which T. cruzi and P. berghei were inoculated
simultaneously, or in which T. cruzi infection started one
week before malaria infection, no protection was
achieved.
Parasitaemia of P. berghei reached ~16% at the peak in
mice with single infection, and around 20–30% in doubly
infected animals (Figure 1B). On the other hand, T. cruzi
blood forms, which are not detectable in a single infection
unless the animals are immunosuppressed by irradiation
or by treatment with cyclophosphamide, could be visual-
ized in most animals co-infected with P. berghei (Figure
1C). This finding is compatible with the immunosuppres-
sive effect induced by malaria infection [15-17]. Although
rendered positive by co-infection, T. cruzi parasitaemia
levels were very low as compared to those of virulent
strains [13].
Symptoms of cerebral malaria are absent and breakdown 
of brain blood barrier is less pronounced in mice co-
infected with T. cruzi
One of the symptoms of C57BL/6 mice with P. berghei
ANKA is the neurological disorder leading to paralysis,
and ultimately to coma and death, characteristic of cere-
bral malaria. In the experiment described in Figure 1, the
majority of mice infected with P. berghei presented signs of
neurological damage before dying. In repeat experiments,
such abnormality was not seen in mice co-infected with T.
cruzi.
Cerebral malaria in mice infected with P. berghei ANKA is
accompanied by mononuclear cell infiltration, haemor-
rhage and cerebral endothelial damage, this damage pre-
sumably being one of the causes of the disruption of the
brain blood barrier [18]. Experiments were performed to
detect the destruction of the blood brain barrier, by inject-
ing mice with the dye Evans blue. C57BL/6 mice were sep-
arated in four groups, two of which were inoculated with
metacyclic forms of T. cruzi G strain. Fifteen days later, one
uninfected and one T. cruzi-infected group were inocu-
lated with P. berghei ANKA. When P. berghei-infected mice
showed signs of neurological disorder, they were given the
dye and one hour later the brain was removed. At this
time, the corresponding number of mice in the co-
infected, T. cruzi-infected or uninfected control groups,
received the dye and the brain was collected one hour
Mortality and course of infection in mice infected with P. berghei ANKA and/or T. cruzi G strainFigure 1
Mortality and course of infection in mice infected with P. 
berghei ANKA and/or T. cruzi G strain. Of three groups of 
C57BL/6 mice from the same batch, two were inoculated 
with T. cruzi metacyclic forms. Fifteen days later, P. berghei-
parasitized erythrocytes were given to the uninfected (n = 6) 
and to one of the T. cruzi-infected group (n = 7), whereas 
one group remained infected with T. cruzi only (n = 6). A) 
Note the increased survival time in co-infected mice, as com-
pared to the group infected with P. berghei only. B) Parasitae-
mia of P. berghei is expressed in percentage of parasitized 
erythrocytes and the values indicate the means ± SD. C) T. 
cruzi parasitaemias of individual mice are shown. Shown are 
the representative data from a set of experiments.Page 3 of 6
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higher the breakdown of the blood brain barrier. The
brains of mice infected with P. berghei were colored in
deep blue whereas most of those from co-infected mice
were light blue (Figure 2). Mice infected only with T. cruzi
had normal brain colour (not shown), indistinguishable
from the normal controls (Figure 2). This result suggests
that, by preventing the extensive destruction of the blood
brain barrier, co-infection with T. cruzi protects against
cerebral malaria.
Co-infection with T. cruzi protects mice from extensive 
pulmonary edema induced by malaria parasites
Pulmonary involvement occurs in 3–10% of individuals
infected with P. falciparum and represents the most serious
complication of this infection, with lethality of about
70% [19]. In severe P. falciparum malaria, the abnormal
vascular change was found to be the cause of pulmonary
oedema [20]. Pulmonary oedema and changes in clotting
and fibrinolysis have been observed during P. berghei
infection in mice [21]. In some experiments of this study,
P. berghei-infected mice suffered from respiratory syn-
drome before dying. This complication appeared around
day 6 or 7 after malaria parasite inoculation and by day 10
all mice were dead. No such complications were found in
mice co-infected with T. cruzi. To determine whether the
observed respiratory distress was associated with pulmo-
nary oedema, within five minutes after death the lung of
P. berghei-infected mice was removed and processed for
histological analysis. At the time of removal, abundant
liquid was noted, possibly resulting from transfer to the
interstitial space and alveoles, as described in P. falciparum
malaria [19]. No such alteration was found in mice co-
infected with T. cruzi, which had their lungs collected at
the time of death of P. berghei-infected animals. Extensive
pulmonary oedema was seen in P. berghei-infected mice,
whereas the cellular infiltration in the lung of co-infected
mice was less pronounced (Figure 3).
Protection to severe malaria and early death conferred by 
co-infection with T. cruzi is similar to that observed in P. 
berghei ANKA-infected mice treated with anti-CD8 
antibodies
According to Belnoue et al. [22], CD8+ T cells, which are
sequestered in the brain of mice at the time of appearance
of neurological symptoms, are responsible for mortality
by cerebral malaria. Analysing mice co-infected with two
Plasmodium species, Voza et al. [23] have found complete
inhibition of P. berghei ANKA-induced cerebral malaria in
mixed infection with Plasmodium yoelii yoeili, but not with
Plasmodium vinckei or another line of P. berghei. In the pro-
tected co-infected mice, the accumulation of CD8+ T cells
in the brain vasculature was found to be inhibited. Here
the degree of protection against P. berghei ANKA infection
conferred by anti-CD8 antibodies, and by co-infection
with T. cruzi, was compared. Both antibody-treated and
co-infected mice survived for more than 20 days (Figure
4), without showing any signs of cerebral malaria or res-
piratory disturbances. Treatment of co-infected mice with
anti-CD8 antibodies did not confer further protection.
The mechanism by which co-infection with T. cruzi con-
fers protection against severe malaria is unknown. An
interesting possibility is that in mixed infection the
sequestration of CD8+ T cells in organs or tissues that are
targets of T. cruzi, such as the heart and skeletal muscles,
results in reduced availability of these cell types for local-
ization in the brain. That possibility exists. Predominance
of CD8+ T lymphocytes in inflammatory cardiac and skel-
etal muscles has been observed in mice with acute T. cruzi
infection [24]. In that study, CD8+ T cells (47.0–58.9%)
significantly outnumbered CD4+ cells (9.3–18.6%). As
regards the pulmonary oedema in severe malaria infec-
tion, it still remains to be determined what induces it. If
CD8+ T cells are also involved, the preferential recruitment
of these cells to organs that are targets of T. cruzi infection,
which do not include lungs, might prevent the accumula-
tion of CD8+ T cells in sufficient numbers to produce
more severe pulmonary alterations.
Breakdown of blood brain barrier in mice infected with P. berghei ANKA or co-infected with T. cruziFigure 2
Breakdown of blood brain barrier in mice infected with P. 
berghei ANKA or co-infected with T. cruzi. C57BL/6 mice 
were separated in 4 groups, two of which were inoculated 
with T. cruzi G strain. Fifteen days later, one uninfected (n = 
5) and one T. cruzi-infected group (n = 5) were inoculated 
with P. berghei ANKA, whereas one group remained unin-
fected (n = 3). When P. berghei-infected mice showed signs of 
neurological disorder, they were given the Evans blue and 1 h 
later the brain was removed. At this time, the corresponding 
number of mice in other groups received the dye and the 
brain was collected 1 h later. Note the difference of brain 
color in the three groups. The brains of the group with single 
T. cruzi infection (n = 5) (not shown) were indistinguishable 
from the normal mice.Page 4 of 6
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Effect of anti-CD8 antibodies on the mortality and course of in i n i  mice infected with P. berghei ANKA or -ed with T. cruzi G stra nFigure 4
Effect of anti-CD8 antibodies on the mortality and course of 
infection in mice infected with P. berghei ANKA or co-
infected with T. cruzi G strain. Of five groups of C57BL/6 
mice, three were inoculated with T. cruzi metacyclic forms. 
Fifteen days later, P. berghei-parasitized erythrocytes were 
given to two uninfected groups (each n = 5), two T. cruzi-
infected group (each n = 5), whereas one group remained 
infected with T. cruzi only (n = 5). On day 0 and 5 of malaria 
infection, one P. berghei-infected and one co-infected group 
were treated with anti-CD8 antibodies. B) Parasitaemia of P. 
berghei is expressed in percentage of parasitized erythrocytes 
and the values indicate the means ± SD.
Pulmonary oedema induced in mice infected with P. berghei ANKA o  c -infected with T. cruziFigure 3
Pulmonary oedema induced in mice infected with P. berghei 
ANKA or co-infected with T. cruzi. C57BL/6 mice were sepa-
rated in three groups, two of which were inoculated with T. 
cruzi G. strain. Fifteen days later, one uninfected (n = 5) and 
one T. cruzi-infected group (n = 5) were inoculated with P. 
berghei ANKA, whereas one group remained uninfected (n = 
3). When P. berghei-infected mice died from respiratory dis-
order, their lungs were collected for histological prepara-
tions and staining with hematoxilin-eosin. At this time, the 
corresponding number of mice in the co-infected group had 
also their lungs removed for histological sections and stain-
ing. Uninfected controls were subjected to the same proce-
dure.
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This study shows for the first time the modulatory effect
of co-infection with T. cruzi on malaria infection that oth-
erwise leads to an early death by cerebral malaria or exten-
sive pulmonary oedema. In most regions where malaria is
endemic, mixed infections are frequent. Therefore, the
varied outcomes of malaria infection may result, at least
in part, from positive or negative regulatory effects of
other pathogens harbored by the patients.
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